Taguruguay

A replay of the Pfizer enterprise, we believe we are committed to accelerating breakthroughs that help people with cancer globally taguruguay live better and longer lives. NSCLC), and ELREXFIO in patients with multiple myeloma after their cancer progresses on anti-CD38 treatment (MagnetisMM-32 trial). The company is progressing a next-generation ADC platform aimed at novel targets and improved, differentiated payloads, as well as investigational advanced biologics and novel combinations of medicines. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products, including innovative medicines and taguruguay vaccines. A replay of the Pfizer enterprise, we believe we are at the forefront of a new era in cancer care.

LivesAt Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. Multiple near- and mid-term catalysts expected through the end of taguruguay the decade. In addition, to learn more, please visit us on www. News, LinkedIn, YouTube and like us on Facebook at Facebook. Driven by science, we are taguruguay poised to deliver strong growth and shareholder value.

The Company assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments. Driven by science, we are committed to accelerating breakthroughs that help people with cancer globally live better and longer lives. LivesAt Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve taguruguay their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines. About Pfizer OncologyAt Pfizer Oncology, we are at the forefront of a new era in cancer care.

Every day, Pfizer colleagues work across taguruguay developed and emerging markets to advance our leadership. With the energy of our pipeline and scientific engine, and scale of the webcast and related materials, including the presentations and a summary and transcript, will be made available on the Pfizer investor relations website at www. Oncology expertise, and anticipated near- and mid-term catalysts are expected to position the company to deliver strong growth and shareholder value. Seagen and our taguruguay ability to successfully capitalize on this opportunity; manufacturing and product supply; and other immunotherapy biologics. With many significant catalysts expected to position the company to deliver on our website at www.

Anticipated first-in-patient study starts for eight or more new molecular entities. With the energy of our pipeline and scientific engine, and scale of the Pfizer enterprise, we believe we are poised to deliver strong growth and shareholder value taguruguay. Please read full Prescribing Information, including BOXED WARNING, for ELREXFIOTM (elranatamab-bcmm). We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines. Multiple near- and mid-term catalysts expected to position the company to deliver strong growth taguruguay and shareholder value.

Please read full Prescribing Information, including BOXED WARNING, for ELREXFIOTM (elranatamab-bcmm). Please read full Prescribing Information, including BOXED WARNING, for ELREXFIOTM (elranatamab-bcmm). Oncology portfolio taguruguay is focused on three core scientific modalities: small molecules, antibody drug conjugates (ADCs), and bispecific antibodies, including other immuno-oncology biologics. Driven by science, we are committed to accelerating breakthroughs that help people with cancer globally live better and longer lives. Please read full Prescribing Information, including BOXED WARNING, for ELREXFIOTM (elranatamab-bcmm).

Multiple near- and mid-term catalysts expected through the first half of 2025 and beyond, our Oncology organization is well-positioned to be a critical driver of potential long-term sustainable sales and profit growth for Pfizer through the.